Shropshire and Mid-Wales Hospice Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2002
NCT00674609
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

dronabinol (marinol) (1 trial)

gw-2000-02 (1 trial)

sativex (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cancer Pain (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3